Live from the NIH registry
Studies recruiting near San Jose right now
Top 25 of 1,132 recruiting studies, sorted by proximity — each links to its official registry page
TBI Rehabilitation and Activation in Veterans
Traumatic Brain Injury
N/A
Interventional 120 participants sought
VA Palo Alto Health Care System — Palo Alto, California (18.9 mi)
· Sponsor: Northern California Institute of Research and Education
SWIR Otoscopy Study
Otitis Media, Otitis Media Chronic
N/A
Interventional 100 participants sought
Stanford University — Palo Alto, California (18.9 mi)
· Sponsor: Stanford University
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Stanford Women's Cancer Center — Palo Alto, California (18.9 mi)
· Sponsor: Relay Therapeutics, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Stanford University Medical Center — Stanford, California (19.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (3.7 mi)
· Sponsor: SWOG Cancer Research Network
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Stanford Hospitals and Clinics — Stanford, California (19.4 mi)
· Sponsor: Cook Research Incorporated
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Lucile Packard Children's Hospital Stanford University — Palo Alto, California (18.9 mi)
· Sponsor: National Cancer Institute (NCI)
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
Board of Trustees of the Leland Stanford Junior University — Stanford, California (19.4 mi)
· Sponsor: Stanford University
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Lucile Packard Children's Hospital, Stanford University — Palo Alto, California (18.9 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
The GAstric Precancerous Conditions Study
Gastric Cancer, Intestinal Metaplasia of Gastric Mucosa
N/A
Observational 600 participants sought
Stanford University — Stanford, California (19.4 mi)
· Sponsor: Stanford University
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
Stanford University — Palo Alto, California (18.9 mi)
· Sponsor: Medstar Health Research Institute
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Stanford University Medical Center — Stanford, California (19.4 mi)
· Sponsor: Edwards Lifesciences
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia
Ventilatory Depression, Postoperative Respiratory Failure
N/A
Interventional 60 participants sought
Stanford University School of Medicine — Stanford, California (19.4 mi)
· Sponsor: Stanford University
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Palo Alto, California (18.9 mi)
· Sponsor: AstraZeneca
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
West Coast Research — Dublin, California (28.1 mi)
· Sponsor: Crystalys Therapeutics
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
Stanford Neuroscience Health Center — Palo Alto, California (18.9 mi)
· Sponsor: Takeda
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Lumos Clinical Research Center /ID# 270582 — San Jose, California (3.7 mi)
· Sponsor: AbbVie
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Stanford University — Palo Alto, California (18.9 mi)
· Sponsor: Jaeb Center for Health Research
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — San Jose, California (3.7 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (3.7 mi)
· Sponsor: NRG Oncology
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
Stanford University Medical Center - Neurology — Stanford, California (19.4 mi)
· Sponsor: Bayer
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
Kaiser Permanente-Division of Research — Pleasanton, California (25.0 mi)
· Sponsor: National Cancer Institute (NCI)
Use of Artificial Intelligence to Assess Trainee Communication Compared to Human Assessment
Communication Skills
N/A
Interventional 45 participants sought
Lucile Packard Children's Hospital Stanford — Palo Alto, California (18.9 mi)
· Sponsor: Stanford University
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Redwood City — Redwood City, California (24.8 mi)
· Sponsor: Guardant Health, Inc.
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
Small Intestinal Bacterial Overgrowth
Phase 1
Interventional 34 participants sought
Silicon Valley Gastroenterology — Mountain View, California (14.2 mi)
· Sponsor: Envivo Bio Inc